Zim Laboratories Ltd
NSE:ZIMLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zim Laboratories Ltd
PP&E Net
Zim Laboratories Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zim Laboratories Ltd
NSE:ZIMLAB
|
PP&E Net
₹2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
PP&E Net
₹111.2B
|
CAGR 3-Years
21%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
PP&E Net
₹69.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
PP&E Net
₹117.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
|
Lupin Ltd
NSE:LUPIN
|
PP&E Net
₹58.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
PP&E Net
₹39.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
Zim Laboratories Ltd
Glance View
Zim Laboratories Ltd. is a pharmaceutical company. The company is headquartered in Nagpur, Maharashtra. The company went IPO on 2018-06-08. The firm develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. The company is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
See Also
What is Zim Laboratories Ltd's PP&E Net?
PP&E Net
2B
INR
Based on the financial report for Mar 31, 2025, Zim Laboratories Ltd's PP&E Net amounts to 2B INR.
What is Zim Laboratories Ltd's PP&E Net growth rate?
PP&E Net CAGR 3Y
24%
Over the last year, the PP&E Net growth was 12%. The average annual PP&E Net growth rates for Zim Laboratories Ltd have been 24% over the past three years .
